Comparison of the new Japanese legislation for expedited approval of regenerative medicine products with the existing systems in the USA and European Union

Publisher： John Wiley & Sons Inc

E-ISSN： 1932-7005|12|2|e1056-e1062

ISSN： 1932-6254

Source： Journal Of Tissue Engineering And Regenerative Medicine, Vol.12, Iss.2, 2018-02, pp. : e1056-e1062

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regenerative medicine: new opportunities for developing countries

By Greenwood Heather L.   Thorsteinsdottir Halla   Perry Gajen   Renihan James   Singer Peter A.   Daar Abdallah S.  

International Journal of Biotechnology, Vol. 8, Iss. 1-2, 2006-02 ,pp. : 60-77

Inderscience Publishers

Access to resources Recommend Favorite

Changes to the European Union pharmaceutical legislation: Implications of the ‘Pharma Review’ for biotechnology companies

By Liikanen Erkki  

Journal of Commercial Biotechnology, Vol. 11, Iss. 1, 2004-10 ,pp. : 38-43

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Cell and biomolecule delivery for regenerative medicine

By  

Science and Technology of Advanced Materials, Vol. 11, Iss. 1, 2010-02 ,pp. : 33-37

IOP Publishing

Access to resources Recommend Favorite

Cell encapsulation using biopolymer gels for regenerative medicine

By Hunt Nicola  

Biotechnology Letters, Vol. 32, Iss. 6, 2010-06 ,pp. : 733-742

Springer Publishing Company

Access to resources Recommend Favorite

New products

By  

Molecular Biotechnology, Vol. 15, Iss. 3, 2000-07 ,pp. : 281-282

Humana Press, Inc

Access to resources Recommend Favorite